The N-Terminally Truncated μ3 and μ3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Andersen, Sonja ^a   Baar, Cecilie ^a   Fladvad, Torill ^a   Laugsand, Eivor Alette ^a   Skorpen, Frank ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CYCLIC AMP; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY; MORPHINE; MORPHINE 6 GLUCURONIDE; MU 3 LIKE OPIATE RECEPTOR; MU 3 OPIATE RECEPTOR; MU OPIATE RECEPTOR; OPIATE; RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN TISSUE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; ENDOPLASMIC RETICULUM; EXON; GENETIC TRANSCRIPTION; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; INTERNALIZATION; NUCLEOTIDE SEQUENCE; OPRM1 GENE; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANALGESICS, OPIOID; BASE SEQUENCE; CELL LINE; CYCLIC AMP; ENDOPLASMIC RETICULUM; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; EXONS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE ORDER; GENES, REPORTER; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; RECEPTORS, OPIOID, MU; TRANSCRIPTION, GENETIC;

EID: 84881509541     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071024     Document Type: Article

References (33)

1. Pasternak GW, Snyder SH, (1975) Identification of novel high affinity opiate receptor binding in rat brain. Nature 253: 563-565.
2. Pasternak GW, Childers SR, Snyder SH, (1980) Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro. J Pharmacol Exp Ther 214: 455-462.
3. Pasternak GW, Childers SR, Snyder SH, (1980) Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Science 208: 514-516.
4. Wolozin BL, Pasternak GW, (1981) Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc Natl Acad Sci U S A 78: 6181-6185.
5. Hahn EF, Carroll-Buatti M, Pasternak GW, (1982) Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines. J Neurosci 2: 572-576.
6. Pan L, Xu J, Yu R, Xu MM, Pan YX, et al. (2005) Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience 133: 209-220.
7. Pasternak DA, Pan L, Xu J, Yu R, Xu MM, et al. (2004) Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy. J Neurochem 91: 881-890.
8. Pan YX, Xu J, Mahurter L, Bolan E, Xu M, et al. (2001) Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc Natl Acad Sci U S A 98: 14084-14089.
9. Pasternak GW, (2004) Multiple opiate receptors: deja vu all over again. Neuropharmacology 47Suppl 1: 312-323.
10. Abbadie C, Pan Y, Drake CT, Pasternak GW, (2000) Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS. Neuroscience 100: 141-153.
11. Abbadie C, Pan YX, Pasternak GW, (2004) Immunohistochemical study of the expression of exon11-containing mu opioid receptor variants in mouse brain. Neuroscience 127: 419-430.
12. Abbadie C, Pasternak GW, (2001) Differential in vivo internalization of MOR-1 and MOR-1C by morphine. Neuroreport 12: 3069-3072.
13. Koch T, Schulz S, Pfeiffer M, Klutzny M, Schroder H, et al. (2001) C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J Biol Chem 276: 31408-31414.
14. Bolan EA, Pan YX, Pasternak GW, (2004) Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm. Synapse 51: 11-18.
15. Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, et al. (1994) Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett 338: 217-222.
16. Pan YX, Xu J, Mahurter L, Xu M, Gilbert AK, et al. (2003) Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X. Biochem Biophys Res Commun 301: 1057-1061.
17. Bare LA, Mansson E, Yang D, (1994) Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett 354: 213-216.
18. Xu J, Xu M, Hurd YL, Pasternak GW, Pan YX, (2009) Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene. J Neurochem 108: 962-972.
19. Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, et al. (2009) Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet 18: 1037-1051.
20. Cadet P, Mantione KJ, Stefano GB, (2003) Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol 170: 5118-5123.
21. Cadet P, Mantione KJ, Zhu W, Kream RM, Sheehan M, et al. (2007) A functionally coupled mu3-like opiate receptor/nitric oxide regulatory pathway in human multi-lineage progenitor cells. J Immunol 179: 5839-5844.
22. Fricchione G, Zhu W, Cadet P, Mantione KJ, Bromfield E, et al. (2008) Identification of endogenous morphine and a mu3-like opiate alkaloid receptor in human brain tissue taken from a patient with intractable complex partial epilepsy. Med Sci Monit 14: CS45-49.
23. Thakker DR, Ozsoy HZ, Standifer KM, (2003) Assessing opioid regulation of adenylyl cyclase activity in intact cells. Methods Mol Med 84: 29-37.
24. Smale ST, Baltimore D, (1989) The "initiator" as a transcription control element. Cell 57: 103-113.
25. Javahery R, Khachi A, Lo K, Zenzie-Gregory B, Smale ST, (1994) DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol Cell Biol 14: 116-127.
26. Gris P, Gauthier J, Cheng P, Gibson DG, Gris D, et al. (2010) A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism. Mol Pain 6: 33.
27. Majumdar S, Grinnell S, Le Rouzic V, Burgman M, Polikar L, et al. (2011) Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects. Proc Natl Acad Sci U S A 108: 19778-19783.
28. Arden JR, Segredo V, Wang Z, Lameh J, Sadee W, (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J Neurochem 65: 1636-1645.
29. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, et al. (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271: 19021-19024.
30. Burford NT, Tolbert LM, Sadee W, (1998) Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I. Eur J Pharmacol. 342: 123-126.
31. Chen LE, Gao C, Chen J, Xu XJ, Zhou DH, et al. (2003) Internalization and recycling of human mu opioid receptors expressed in Sf9 insect cells. Life Sci 73: 115-128.
32. Du YL, Elliot K, Pan YX, Pasternak GW, Inturrisi CE, (1997) A splice variant of the mu opioid receptor is present in human SHSY-5Y cells. Soc Neurosci 23: 1206.
33. Choi HS, Kim CS, Hwang CK, Song KY, Wang W, et al. (2006) The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor. Biochem Biophys Res Commun 343: 1132-1140.